Colorado Blood Cancer Institute - PPDS — Denver, Colorado

Colorado Blood Cancer Institute - PPDS is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute - PPDS has participated in 3 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Sponsors: Takeda, Bristol-Myers Squibb, Shire.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute - PPDS?

Colorado Blood Cancer Institute - PPDS has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute - PPDS conducted?

Colorado Blood Cancer Institute - PPDS has 3 clinical trials on record. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Is Colorado Blood Cancer Institute - PPDS accredited by Crixeo Health?

Colorado Blood Cancer Institute - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.